Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
August 3, 2020
Primary Completion Date
March 5, 2021
Study Completion Date
March 5, 2021
Conditions
Healthy Volunteer
Interventions
DRUG
Pozelimab
Single subcutaneous (SC) injection
Trial Locations (1)
B-2060
Regeneron Study Site, Antwerp
All Listed Sponsors
lead
Regeneron Pharmaceuticals
INDUSTRY
NCT04491838 - Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants | Biotech Hunter | Biotech Hunter